Today (2017 C.E. - 2025 C.E.)

This archive spans the years 2017 through 2025, a period marked by rapid advances in clean energy, medicine, technology, and social equity. It collects documented breakthroughs, policy wins, and scientific achievements from the present era. If you want evidence that progress is real and ongoing, this is where to look.

Lynx, for article on Iberian highlands rewilding

Lynx, wild horses and vultures return to eastern Spain in latest rewilding project

Rewilding Europe’s first project in Spain is bringing an 850,000-acre mountain landscape back to life — and the early signs are genuinely hopeful. Wild horses are already breeding, black vultures are being released at up to 15 a year, and Iberian lynx are expected within two years. The project is also designed around local communities, creating economic incentives for nature-based tourism and forest protection. Stories like this show that recovery is possible when wildlife, people, and landscape are treated as one connected system.

Artwork of path into mind, for article on Colorado psychedelic decriminalization

Colorado voters pass historic psychedelic decriminalization act

Colorado’s Natural Medicine Health Act goes further than any previous U.S. state psychedelic law, removing criminal penalties for personal use of psilocybin, DMT, ibogaine, and mescaline — and building a licensed therapy clinic system alongside it. The FDA has already granted psilocybin “breakthrough therapy” status for treatment-resistant depression, giving this reform unusual clinical credibility. Colorado helped pioneer cannabis legalization in 2012, and advocates are watching to see whether psychedelic reform follows a similar path outward. For people who haven’t found relief through conventional treatments, this law opens a genuinely new door.

Blood cells under microscope, for article on smart insulin, for article on lab-grown blood cells

First human patients receive transfusions of lab-grown blood cells

Lab-grown blood cells have reached a genuine turning point: manufactured red blood cells grown from stem cells have been safely transfused into human patients for the first time. What makes these cells special is their freshness — unlike donated blood, every lab-grown cell is the same age, meaning they should last closer to the full 120-day lifespan and reduce repeat transfusions. Early participants completed the process with no adverse effects. For millions worldwide living with blood disorders or rare blood types, this science crossing into human trials is the kind of progress that quietly changes everything.